Suppr超能文献

2008 年全球宫颈癌负担。

Worldwide burden of cervical cancer in 2008.

机构信息

Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium; European Cooperation on Development and Implementation of Cancer Screening and Prevention Guidelines, International Agency for Research on Cancer, Lyon, France; Health-Economic Modelling of Prevention Strategies for HPV-Related Diseases in European Countries, Free University of Amsterdam, Amsterdam, The Netherlands.

Health-Economic Modelling of Prevention Strategies for HPV-Related Diseases in European Countries, Free University of Amsterdam, Amsterdam, The Netherlands; Unit of Infections and Cancer, Catalonian Institute of Oncology, Barcelona; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Barcelona, Spain.

出版信息

Ann Oncol. 2011 Dec;22(12):2675-2686. doi: 10.1093/annonc/mdr015. Epub 2011 Apr 6.

Abstract

BACKGROUND

The knowledge that persistent human papillomavirus infection is the main cause of cervical cancer has resulted in the development of assays that detect nucleic acids of the virus and prophylactic vaccines. Up-to-date and reliable data are needed to assess impact of existing preventive measures and to define priorities for the future.

MATERIALS AND METHODS

Best estimates on cervical cancer incidence and mortality are presented using recently compiled data from cancer and mortality registries for the year 2008.

RESULTS

There were an estimated 530,000 cases of cervical cancer and 275,000 deaths from the disease in 2008. It is the third most common female cancer ranking after breast (1.38 million cases) and colorectal cancer (0.57 million cases). The incidence of cervical cancer varies widely among countries with world age-standardised rates ranging from <1 to >50 per 100,000. Cervical cancer is the leading cause of cancer-related death among women in Eastern, Western and Middle Africa; Central America; South-Central Asia and Melanesia. The highest incidence rate is observed in Guinea, with ∼6.5% of women developing cervical cancer before the age of 75 years. India is the country with the highest disease frequency with 134,000 cases and 73 000 deaths. Cervical cancer, more than the other major cancers, affects women <45 years.

CONCLUSIONS

In spite of effective screening methods, cervical cancer continues to be a major public health problem. New methodologies of cervical cancer prevention should be made available and accessible for women of all countries through well-organised programmes.

摘要

背景

人乳头瘤病毒(HPV)持续感染是宫颈癌的主要病因,这一认识导致了针对 HPV 核酸的检测方法和预防性疫苗的发展。为了评估现有预防措施的效果并确定未来的工作重点,需要掌握最新和可靠的数据。

材料与方法

使用最新汇编的癌症和死亡率登记处 2008 年的数据,对宫颈癌发病率和死亡率进行了最佳评估。

结果

2008 年估计有 53 万宫颈癌新发病例和 27.5 万宫颈癌死亡病例。宫颈癌在女性中发病率排名第三,仅次于乳腺癌(138 万例)和结直肠癌(57 万例)。宫颈癌在各国的发病率差异很大,全球年龄标准化发病率范围为每 10 万人<1 至>50 例。宫颈癌是东非、西非和中非;中美洲;南亚和中亚以及美拉尼西亚地区女性癌症相关死亡的主要原因。宫颈癌发病率最高的国家是几内亚,75 岁之前有 6.5%的女性会发展为宫颈癌。印度是发病人数最多的国家,有 13.4 万例新发病例和 7.3 万例死亡病例。宫颈癌与其他主要癌症相比,更多地影响 45 岁以下的女性。

结论

尽管有有效的筛查方法,但宫颈癌仍然是一个主要的公共卫生问题。应通过组织良好的方案,为所有国家的妇女提供新的宫颈癌预防方法,并确保其可及性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验